These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 18180842)
1. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases]. Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842 [TBL] [Abstract][Full Text] [Related]
2. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression. Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121 [TBL] [Abstract][Full Text] [Related]
3. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate]. Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732 [TBL] [Abstract][Full Text] [Related]
5. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)]. Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717 [TBL] [Abstract][Full Text] [Related]
6. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients]. Bar-Sela G; Lev LM; Kuten A; Wollner M; Haim N Harefuah; 2006 Jan; 145(1):2-7, 80. PubMed ID: 16450715 [TBL] [Abstract][Full Text] [Related]
8. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors? Yoon SS; Tanabe KK Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951 [No Abstract] [Full Text] [Related]
9. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case. Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500 [TBL] [Abstract][Full Text] [Related]
12. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234 [TBL] [Abstract][Full Text] [Related]
13. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)]. Láng I; Hitre E Orv Hetil; 2005 May; 146(18 Suppl 1):935-41. PubMed ID: 15921308 [TBL] [Abstract][Full Text] [Related]
14. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774 [TBL] [Abstract][Full Text] [Related]
15. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors]. Wan DS; Wu XJ; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Ding PR Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3064-7. PubMed ID: 17288838 [TBL] [Abstract][Full Text] [Related]
16. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor]. Shen L; Jin ML Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512 [TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate therapy in advanced gastrointestinal stromal tumors: experience from a single institute. Hsiao HH; Liu YC; Tsai HJ; Chen LT; Lee CP; Chuan CH; Wang JY; Yang SF; Tseng YT; Lin SF Kaohsiung J Med Sci; 2006 Dec; 22(12):599-603. PubMed ID: 17116620 [TBL] [Abstract][Full Text] [Related]
18. Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate. Wardelmann E; Merkelbach-Bruse S; Pauls K; Thomas N; Schildhaus HU; Heinicke T; Speidel N; Pietsch T; Buettner R; Pink D; Reichardt P; Hohenberger P Clin Cancer Res; 2006 Mar; 12(6):1743-9. PubMed ID: 16551858 [TBL] [Abstract][Full Text] [Related]
19. Does imatinib turn recurrent and/or metastasized gastrointestinal stromal tumors into a chronic disease? - single center experience. Armbrust T; Sobotta M; Gunawan B; Füzesi L; Langer C; Cameron S; Ramadori G Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):819-23. PubMed ID: 19369884 [TBL] [Abstract][Full Text] [Related]
20. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib]. Sakakura C; Miyagawa K; Fukuda K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Yamaoka N; Sagara Y; Hagiwara A; Yamagishi H Gan To Kagaku Ryoho; 2005 Oct; 32(11):1739-41. PubMed ID: 16315926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]